Nathaniel Zilkha, a principal with Kohlberg Kravis Roberts & Co., has joined the board of KKR portfolio company Jazz Pharmaceuticals Inc. (Nasdaq: JAZZ). He replaces KKR colleague Adam Clammer. www.jazzpharmaceuticals.com
Nathaniel Zilkha, a principal with Kohlberg Kravis Roberts & Co., has joined the board of KKR portfolio company Jazz Pharmaceuticals Inc. (Nasdaq: JAZZ). He replaces KKR colleague Adam Clammer. www.jazzpharmaceuticals.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.